Trial reportPloS one2018
Diffusion spectrum imaging in white matter microstructure in subjects with type 2 diabetes.
Trial report in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Diffusion Magnetic Resonance Imaging Models for Detecting Brain Microstructural Abnormalities in Type 2 Diabetes: A Systematic Review.Bioengineering (Basel, Switzerland) · 2026Review
- White Matter Characteristics of Damage Along Fiber Tracts in Patients with Type 2 Diabetes Mellitus.Clinical neuroradiology · 2023Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to investigate the feasibility and clinical applicability of Diffusion Spectrum Imaging (DSI) for quantitative detection of white matter microstructural integrity. Twenty-seven patients with type 2 diabetes mellitus (T2DM; aged 60.6±7.6 years) and 21 healthy controls (HC; aged 56.1±7.8 years) underwent high-resolution T1-weighted imaging and DSI scanning. Cognitive function scores were obtained using such instruments as the Montreal Cognitive Assessment (MoCA). The fasting blood glucose, glycated hemoglobin, and total cholesterol (CHO) of T2DM were measured. The bilateral uncinate fasciculus and superior cingulum bundle were reconstructed by DSI tractography. Statistical analysis was performed using SPSS 21.0 software and P<0.05 was considered significant. Generalized fractional anisotropy (GFA) values were significantly decreased in the left uncinate fasciculus (t = -2.915, p = 0.005) and right superior cingulum bundle (t = -2.604, p = 0.012) in T2DM patients compared with the healthy controls (p<0.05). The MoCA (t = -3.339, p = 0.002) and CDT (t = -3.039, p = 0.004) scores of T2DM were significantly lower than those of healthy controls. Meanwhile, the GFA value of the right superior cingulum bundle was negatively associated with VFT score (r = -0.475, p = 0.012), and that of the right superior cingulum bundle was negatively associated with blood CHO level (r = -0.458, p = 0.016). DSI tractography is capable of evaluating the microstructural integrity of the white matter bundle in T2DM and is related to clinical cognitive scores and related biochemical indices; therefore, it can help to predict early white matter abnormalities in T2DM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.